First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings.
Crit Rev Oncol Hematol. 2021 Jan;157:103198. doi: 10.1016/j.critrevonc.2020.103198. Epub 2020 Dec 13.
Crit Rev Oncol Hematol. 2021.
PMID: 33316417